Biodesix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biodesix generated cash of -$22,870,000, which is more than the previous year. Cash used in financing activities reached the amount of $29,129,000 last year. Net change in cash is therefore -$16,803,000.
Cash Flow
| 2018 | -17.67M | -617K | 19.03M |
|---|---|---|---|
| 2019 | -21.72M | -1.87M | 22.97M |
| 2020 | -21.36M | -2.92M | 81.13M |
| 2021 | -28.22M | -2.54M | 1.26M |
| 2022 | -44.97M | -3.53M | 58.88M |
| 2023 | -22.87M | -23.06M | 29.12M |
BDSX Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 43.17M | 32.79M | 62.30M | 5.46M | 6.09M | 5.35M |
Operating activities | ||||||
Net income | -52.14M | -65.44M | -43.15M | -31.35M | -30.72M | -26.16M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 5.50M | 5.84M | 3.17M | 2.90M | 2.79M | 1.74M |
Stock-based compensation expense | 5.37M | 5.96M | 4.94M | 3.70M | 170K | 0 |
| Deferred income tax benefit | 5.37M | 5.96M | 4.94M | 3.70M | 170K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -4.71M | -1.50M | 11.45M | -10.30M | -3.64M | -146K |
Inventories | 166K | 906K | 7.42M | -11.65M | 17K | -389K |
Accounts payable | 513K | -773K | -7.42M | 11.65M | 1.19M | 342K |
Cash generated by operating activities | -22.87M | -44.97M | -28.22M | -21.36M | -21.72M | -17.67M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -22.91M | -3.53M | -2.54M | -2.17M | -1.41M | -617K |
Acquisitions Net | 0 | 0 | 0 | -750K | -456K | 0 |
Cash generated by investing activities | -23.06M | -3.53M | -2.54M | -2.92M | -1.87M | -617K |
Financing activities | ||||||
Common Stock Issued | 28.12M | 59.53M | 17.44M | 72M | 10.04M | 31.55M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 9.95M | 16.49M | -15.35M | -7.79M | 13.04M | -22.51M |
Cash used in financing activities | 29.12M | 58.88M | 1.26M | 81.13M | 22.97M | 19.03M |
Net Change In Cash | -16.80M | 10.37M | -29.50M | 56.83M | -626K | 738K |
Cash at end of period | 26.37M | 43.17M | 32.79M | 62.30M | 5.46M | 6.09M |
| Data source | Data source | Data source | Data source |